Increased numbers of GZMB+ cells in the TIME have been linked to a favorable prognosis in some tumors including cervical intraepithelial neoplasia [46], oral squamous cell carcinoma [47], and melanoma [48]. This evidence concerns the gene GZMB and cervical intraepithelial neoplasia.